Page last updated: 2024-08-21

oleanolic acid and 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-

oleanolic acid has been researched along with 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)- in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Feng, Y; Gu, L; Guo, J; Jiang, H; Li, Y; Liao, S; Ma, L; Sun, M; Wang, H; Wen, H; Yu, X; Zeng, B; Zhou, Y1

Other Studies

1 other study(ies) available for oleanolic acid and 9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-

ArticleYear
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathways.
    Biochemical pharmacology, 2017, 07-01, Volume: 135

    Topics: Adult; Aged; Animals; Antineoplastic Agents; Benzodioxoles; Carcinoma, Non-Small-Cell Lung; CDC2-CDC28 Kinases; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Follow-Up Studies; HSP90 Heat-Shock Proteins; Humans; Lung Neoplasms; Male; MAP Kinase Kinase Kinases; MAP Kinase Signaling System; Mice; Mice, Nude; Middle Aged; Oleanolic Acid; Purines; Retrospective Studies; Tumor Burden; Tumor Cells, Cultured

2017